<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32754913</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-4159</ISSN><JournalIssue CitedMedium="Internet"><Volume>157</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of neurochemistry</Title><ISOAbbreviation>J Neurochem</ISOAbbreviation></Journal><ArticleTitle>Detergent-insoluble inclusion constitutes the first pathology in PFN1 transgenic rats.</ArticleTitle><Pagination><StartPage>1244</StartPage><EndPage>1252</EndPage><MedlinePgn>1244-1252</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jnc.15139</ELocationID><Abstract><AbstractText>Mutation of profilin 1 (PFN1) can cause amyotrophic lateral sclerosis (ALS). To assess how PFN1 mutation causes the disease, we created transgenic rats with human genomic DNA that harbors both the coding and the regulatory sequences of the human PFN1 gene. Selected transgenic lines expressed human PFN1 with or without the pathogenic mutation C71G at a moderate and a comparable level and in the similar pattern of spatial and temporal expression to rat endogenous PFN1. The artificial effects of arbitrary transgene expression commonly observed in cDNA transgenic animals were minimized in PFN1 transgenic rats. Expression of the mutant, but not the wild type, human PFN1 in rats recapitulated the cardinal features of ALS including the progressive loss of motor neurons and the subsequent denervation atrophy of skeletal muscles. Detergent-insoluble PFN1 inclusions were detected as the first pathology in otherwise asymptomatic transgenic rats expressing mutant human PFN1. The findings suggest that protein aggregation is involved in the neurodegeneration of ALS associated with PFN1 mutation. The resulting rat model is useful to mechanistic study on the ALS.</AbstractText><CopyrightInformation>&#xa9; 2020 International Society for Neurochemistry.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Guixiu</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Shiquan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Haochang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Cao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pathology, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Jianbin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Zhentin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Xinrui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Jihe</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pathology, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Qinxue</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Pathology, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yibo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Gong</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Hongxia</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Xu-Gang</ForeName><Initials>XG</Initials><Identifier Source="ORCID">0000-0002-1114-9666</Identifier><AffiliationInfo><Affiliation>Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, FL, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NS110455</GrantID><Agency>National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke</Agency><Country/></Grant><Grant><GrantID>R01 NS073829</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS07829</GrantID><Agency>National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke</Agency><Country/></Grant><Grant><GrantID>AG064822</GrantID><Agency>NIH/National Institute on Aging</Agency><Country/></Grant><Grant><GrantID>NS089701</GrantID><Agency>National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke</Agency><Country/></Grant><Grant><GrantID>RF1 AG064822</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS095962</GrantID><Agency>National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke</Agency><Country/></Grant><Grant><GrantID>R01 NS115039</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS095962</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS110455</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS089701</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neurochem</MedlineTA><NlmUniqueID>2985190R</NlmUniqueID><ISSNLinking>0022-3042</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495738">PFN1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051304">Profilins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002479" MajorTopicYN="N">Inclusion Bodies</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051304" MajorTopicYN="N">Profilins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055647" MajorTopicYN="N">Rats, Transgenic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">PFN1</Keyword><Keyword MajorTopicYN="N">aggregation</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">rat</Keyword></KeywordList><CoiStatement>CONFLICT OF INTEREST. Xugang Xia is an editor for <i>Journal of Neurochemistry.</i></CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32754913</ArticleId><ArticleId IdType="mid">NIHMS1789986</ArticleId><ArticleId IdType="pmc">PMC8994973</ArticleId><ArticleId IdType="doi">10.1111/jnc.15139</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Boopathy S, Silvas TV, Tischbein M, Jansen S, Shandilya SM, Zitzewitz JA, &#x2026; Bosco DA (2015). Structural basis for mutation-induced destabilization of profilin 1 in ALS. Proceedings of the National Academy of Sciences of the United States of America, 112, 7984&#x2013;7989. 10.1073/pnas.1424108112</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1424108112</ArticleId><ArticleId IdType="pmc">PMC4491777</ArticleId><ArticleId IdType="pubmed">26056300</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruggink KA, Muller M, Kuiperij HB, &amp; Verbeek MM (2012). Methods for analysis of amyloid-beta aggregates. Journal of Alzheimer's Disease, 28, 735&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pubmed">22156047</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J Stefani M (2002). Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature, 416, 507&#x2013;511. 10.1038/416507a</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/416507a</ArticleId><ArticleId IdType="pubmed">11932737</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheroni C, Marino M, Tortarolo M, Veglianese P, De Biasi S, Fontana E, Bendotti C (2009). Functional alterations of the ubiquitin-proteasome system in motor neurons of a mouse model of familial amyotrophic lateral sclerosis. Human Molecular Genetics, 18, 82&#x2013;96. 10.1093/hmg/ddn319</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn319</ArticleId><ArticleId IdType="pmc">PMC3298865</ArticleId><ArticleId IdType="pubmed">18826962</ArticleId></ArticleIdList></Reference><Reference><Citation>Creed RB, &amp; Goldberg MS (2018). New Developments in genetic rat models of Parkinson's disease. Movement Disorders, 33, 717&#x2013;729. 10.1002/mds.27296</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.27296</ArticleId><ArticleId IdType="pmc">PMC5992003</ArticleId><ArticleId IdType="pubmed">29418019</ArticleId></ArticleIdList></Reference><Reference><Citation>Dave KD, De Silva S, Sheth NP, Ramboz S, Beck MJ, Quang C, &#x2026; Frasier MA (2014). Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease. Neurobiology of Diseases, 70, 190&#x2013;203. 10.1016/j.nbd.2014.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.06.009</ArticleId><ArticleId IdType="pubmed">24969022</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Poggetto E, Bemporad F, Tatini F, &amp; Chiti F (2015). Mutations of Profilin-1 associated with amyotrophic lateral sclerosis promote aggregation due to structural changes of its Native State. ACS Chemical Biology, 10, 2553&#x2013;2563. 10.1021/acschembio.5b00598</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschembio.5b00598</ArticleId><ArticleId IdType="pubmed">26226631</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Nardo A, Gareus R, Kwiatkowski D, &amp; Witke W (2000). Alternative splicing of the mouse profilin II gene generates functionally different profilin isoforms. Journal of Cell Science, 113(Pt 21), 3795&#x2013;3803.</Citation><ArticleIdList><ArticleId IdType="pubmed">11034907</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Z, Joy M, Bhargava R, Gunsaulus M, Lakshman N, Miron-Mendoza M, &#x2026; Roy P (2014). Profilin-1 downregulation has contrasting effects on early vs late steps of breast cancer metastasis. Oncogene, 33, 2065&#x2013;2074. 10.1038/onc.2013.166</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2013.166</ArticleId><ArticleId IdType="pmc">PMC3834125</ArticleId><ArticleId IdType="pubmed">23686314</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Y, Arif A, Gong Y et al. (2012). Stimulus-dependent phosphorylation of profilin-1 in angiogenesis. Nature Cell Biology, 14, 1046&#x2013;1056.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3619429</ArticleId><ArticleId IdType="pubmed">23000962</ArticleId></ArticleIdList></Reference><Reference><Citation>Fil D, DeLoach A, Yadav S et al. (2017). Mutant profilin1 transgenic mice recapitulate cardinal features of motor neuron disease. Human Molecular Genetics, 26, 686&#x2013;701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5968635</ArticleId><ArticleId IdType="pubmed">28040732</ArticleId></ArticleIdList></Reference><Reference><Citation>Gau D, Lewis T, McDermott L, Wipf P, Koes D, &amp; Roy P (2018). Structure-based virtual screening identifies a small-molecule inhibitor of the profilin 1-actin interaction. Journal of Biological Chemistry, 293, 2606&#x2013;2616. 10.1074/jbc.M117.809137</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.809137</ArticleId><ArticleId IdType="pmc">PMC5818201</ArticleId><ArticleId IdType="pubmed">29282288</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedert M, Spillantini MG, Del Tredici K, &amp; Braak H (2012). 100 years of Lewy pathology. Nature Reviews. Neurology, 9, 13&#x2013;24. 10.1038/nrneurol.2012.242</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2012.242</ArticleId><ArticleId IdType="pubmed">23183883</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorlich A, Zimmermann AM, Schober D, Bottcher RT, Sassoe-Pognetto M, Friauf E, &#x2026; Rust MB (2012). Preserved morphology and physiology of excitatory synapses in profilin1-deficient mice. PLoS One, 7, e30068. 10.1371/journal.pone.0030068</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0030068</ArticleId><ArticleId IdType="pmc">PMC3256187</ArticleId><ArticleId IdType="pubmed">22253883</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Tong J, Bi F, Wu Q, Huang B, Zhou H, &amp; Xia XG (2012). Entorhinal cortical neurons are the primary targets of FUS mislocalization and ubiquitin aggregation in FUS transgenic rats. Human Molecular Genetics, 21, 4602&#x2013;4614. 10.1093/hmg/dds299</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds299</ArticleId><ArticleId IdType="pmc">PMC3471393</ArticleId><ArticleId IdType="pubmed">22833456</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Tong J, Bi F, Zhou H, &amp; Xia XG (2012). Mutant TDP-43 in motor neurons promotes the onset and progression of ALS in rats. J Clin Invest, 122, 107&#x2013;118. 10.1172/JCI59130</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI59130</ArticleId><ArticleId IdType="pmc">PMC3248298</ArticleId><ArticleId IdType="pubmed">22156203</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Zhou H, Tong J, Chen H, Liu Y-J, Wang D, &#x2026; Xia X-G (2011). FUS transgenic rats develop the phenotypes of amyotrophic lateral sclerosis and frontotemporal lobar degeneration. PLOS Genetics, 7, e1002011. 10.1371/journal.pgen.1002011</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002011</ArticleId><ArticleId IdType="pmc">PMC3048370</ArticleId><ArticleId IdType="pubmed">21408206</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito D, &amp; Suzuki N (2009). Seipinopathy: A novel endoplasmic reticulum stress-associated disease. Brain, 132, 8&#x2013;15. 10.1093/brain/awn216</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awn216</ArticleId><ArticleId IdType="pubmed">18790819</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwong LK, Neumann M, Sampathu DM, Lee VM, &amp; Trojanowski JQ (2007). TDP-43 proteinopathy: The neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease. Acta Neuropathologica, 114, 63&#x2013;70. 10.1007/s00401-007-0226-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0226-5</ArticleId><ArticleId IdType="pubmed">17492294</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwong LK, Uryu K, Trojanowski JQ, &amp; Lee VM (2008). TDP-43 proteinopathies: Neurodegenerative protein misfolding diseases without amyloidosis. Neurosignals, 16, 41&#x2013;51. 10.1159/000109758</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000109758</ArticleId><ArticleId IdType="pubmed">18097159</ArticleId></ArticleIdList></Reference><Reference><Citation>Luk KC, Kehm V, Carroll J, Zhang B, O'Brien P, Trojanowski JQ, &amp; Lee VM (2012). Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science, 338, 949&#x2013;953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3552321</ArticleId><ArticleId IdType="pubmed">23161999</ArticleId></ArticleIdList></Reference><Reference><Citation>Luk KC, Kehm VM, Zhang B, O'Brien P, Trojanowski JQ, &amp; Lee VM (2012). Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. Journal of Experimental Medicine, 209, 975&#x2013;986.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3348112</ArticleId><ArticleId IdType="pubmed">22508839</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaelsen K, Murk K, Zagrebelsky M, Dreznjak A, Jockusch BM, Rothkegel M, &amp; Korte M (2010). Fine-tuning of neuronal architecture requires two profilin isoforms. Proceedings of the National Academy of Sciences, 107, 15780&#x2013;15785. 10.1073/pnas.1004406107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1004406107</ArticleId><ArticleId IdType="pmc">PMC2936622</ArticleId><ArticleId IdType="pubmed">20798032</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, &#x2026; Lee V-M-Y (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314, 130&#x2013;133. 10.1126/science.1134108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HP, Van Broeckhoven C, &amp; van der Zee J (2018). ALS Genes in the Genomic Era and their Implications for FTD. Trends in Genetics, 34, 404&#x2013;423. 10.1016/j.tig.2018.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2018.03.001</ArticleId><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Rennella E, Sekhar A, &amp; Kay LE (2017). Self-assembly of human profilin-1 detected by Carr-Purcell-Meiboom-Gill nuclear magnetic resonance (CPMG NMR) spectroscopy. Biochemistry 56, 692&#x2013;703. 10.1021/acs.biochem.6b01263</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.6b01263</ArticleId><ArticleId IdType="pubmed">28052669</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez JA, Ivanova MI, Sawaya MR et al. (2015). Structure of the toxic core of alpha-synuclein from invisible crystals. Nature, 525, 486&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4791177</ArticleId><ArticleId IdType="pubmed">26352473</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero S, Le Clainche C, Didry D, Egile C, Pantaloni D, &amp; Carlier MF (2004). Formin is a processive motor that requires profilin to accelerate actin assembly and associated ATP hydrolysis. Cell, 119, 419&#x2013;429. 10.1016/j.cell.2004.09.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2004.09.039</ArticleId><ArticleId IdType="pubmed">15507212</ArticleId></ArticleIdList></Reference><Reference><Citation>Sifers RN, Brashears-Macatee S, Kidd VJ, Muensch H, &amp; Woo SL (1988). A frameshift mutation results in a truncated alpha 1-antitrypsin that is retained within the rough endoplasmic reticulum. Journal of Biological Chemistry, 263, 7330&#x2013;7335.</Citation><ArticleIdList><ArticleId IdType="pubmed">3259232</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith BN, Vance C, Scotter EL, Troakes C, Wong CH, Topp S, &#x2026; Shaw CE (2015). Novel mutations support a role for Profilin 1 in the pathogenesis of ALS. Neurobiology of Aging, 36(1602), 1602.e17&#x2013;1602.e27. 10.1016/j.neurobiolaging.2014.10.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.10.032</ArticleId><ArticleId IdType="pmc">PMC4357530</ArticleId><ArticleId IdType="pubmed">25499087</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH Jr, &amp; Cleveland DW (2016). Decoding ALS: From genes to mechanism. Nature, 539, 197&#x2013;206. 10.1038/nature20413</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong J, Huang C, Bi F, Wu Q, Huang B, Liu X, &#x2026; Xia XG (2013). Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats. EMBO Journal, 32, 1917&#x2013;1926. 10.1038/emboj.2013.122</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2013.122</ArticleId><ArticleId IdType="pmc">PMC3981181</ArticleId><ArticleId IdType="pubmed">23714777</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, &#x2026; Selkoe DJ (2002). Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature, 416, 535&#x2013;539.</Citation><ArticleIdList><ArticleId IdType="pubmed">11932745</ArticleId></ArticleIdList></Reference><Reference><Citation>Warming S, Costantino N, Court DL, Jenkins NA, &amp; Copeland NG (2005). Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Research, 33, e36. 10.1093/nar/gni035</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gni035</ArticleId><ArticleId IdType="pmc">PMC549575</ArticleId><ArticleId IdType="pubmed">15731329</ArticleId></ArticleIdList></Reference><Reference><Citation>Witke W (2004). The role of profilin complexes in cell motility and other cellular processes. Trends in Cell Biology, 14, 461&#x2013;469. 10.1016/j.tcb.2004.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2004.07.003</ArticleId><ArticleId IdType="pubmed">15308213</ArticleId></ArticleIdList></Reference><Reference><Citation>Witke W, Sutherland JD, Sharpe A, Arai M, &amp; Kwiatkowski DJ (2001). Profilin I is essential for cell survival and cell division in early mouse development. Proceedings of the National Academy of Sciences of the United States of America, 98, 3832&#x2013;3836. 10.1073/pnas.051515498</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.051515498</ArticleId><ArticleId IdType="pmc">PMC31138</ArticleId><ArticleId IdType="pubmed">11274401</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C-H, Fallini C, Ticozzi N, Keagle PJ, Sapp PC, Piotrowska K, &#x2026; Landers JE (2012). Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature, 488, 499&#x2013;503. 10.1038/nature11280</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11280</ArticleId><ArticleId IdType="pmc">PMC3575525</ArticleId><ArticleId IdType="pubmed">22801503</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Liu M, Huang C, Liu X, Huang B, Li N, &#x2026; Xia XG (2015). Pathogenic Ubqln2 gains toxic properties to induce neuron death. Acta Neuropathologica, 129, 417&#x2013;428. 10.1007/s00401-014-1367-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1367-y</ArticleId><ArticleId IdType="pmc">PMC4777328</ArticleId><ArticleId IdType="pubmed">25388785</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Danielson EW, Qiao T, Metterville J, Brown RH Jr, Landers JE, &amp; Xu Z (2016). Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity. Proceedings of the National Academy of Sciences, 113, E6209&#x2013;E6218. 10.1073/pnas.1605964113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1605964113</ArticleId><ArticleId IdType="pmc">PMC5068285</ArticleId><ArticleId IdType="pubmed">27681617</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Huang C, Chen H, Wang D, Landel CP, Xia PY, &#x2026; Xia XG (2010). transgenic rat model of neurodegeneration caused by mutation in the TDP gene. PLOS Genetics, 6, e1000887. 10.1371/journal.pgen.1000887</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000887</ArticleId><ArticleId IdType="pmc">PMC2845661</ArticleId><ArticleId IdType="pubmed">20361056</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Huang C, Yang M, Landel CP, Xia PY, Liu YJ, &amp; Xia XG (2009). Developing tTA transgenic rats for inducible and reversible gene expression. International Journal of Biological Sciences, 2, 171&#x2013;181. 10.7150/ijbs.5.171</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.5.171</ArticleId><ArticleId IdType="pmc">PMC2640494</ArticleId><ArticleId IdType="pubmed">19214245</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>